Eli Lilly and (LLY) Revenue — Quarter Ended Jun 30, 2024
Eli Lilly reported higher revenue for the quarter, marking a continuation of its growth trend. The increase was significant when compared to both the preceding quarter and the same quarter one year earlier.
Key takeaway
Quarter ended Jun 30, 2024 · FY2024 Q2
Eli Lilly reported higher revenue for the quarter, marking a continuation of its growth trend. The increase was significant when compared to both the preceding quarter and the same quarter one year earlier.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$11.3B
Revenue reported for this quarter.
Quarter-over-quarter
+28.9%
Change from the immediately preceding quarter.
Year-over-year
+36.0%
Change from the comparable year-ago quarter.
Trailing four quarters
$38.9B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2023 | $9.5B | +36.8% |
| Dec 31, 2023 | $9.4B | +28.1% |
| Mar 31, 2024 | $8.8B | +26.0% |
| Jun 30, 2024 | $11.3B | +36.0% |
Revenue performance
Revenue growth was robust, with the quarterly figure exceeding that of the prior three-month period and the comparable period from a year ago.
Quarterly comparison
Compared to the immediately preceding quarter, revenue expanded, and it also rose relative to the same quarter a year prior.
What to watch
The consistent upward movement in revenue across sequential and annual comparisons is a notable aspect of this quarter's results.